// Dr Martens set to be sold to US private equity firm Carlyle Group LP for £300m
// The news comes after KKR dropped out of a potential deal
// It is currently owned by UK-based investment firm Permira
Dr Martens is reportedly set to be acquired by US private equity firm Carlyle Group LP for £300 million.
Carlyle is currently the interested party in talks with Dr Martens to acquire it after rival firm KKR dropped out of a potential deal, the Mail on Sunday reported.
The British footwear and clothing retailer is currently owned by UK-based investment firm Permira, which bought it in 2014 for around £300 million.
READ MORE: Dr Martens in talks with Carlyle as potential new owner
Dr Martens has been in talks with Carlyle since November, when it emerged that a deal could potentially value the retailer at £1 billion.
At the time, Bloomberg broke the news of the potential deal, and it was thought that negotiations were in early stages and there was no certainty as to whether a deal would emerge.
Last year, reports also emerged that Permira was working with Goldman Sachs Group Inc and Robert W. Baird & Co to consider selling Dr Martens or float it on the US stock market.
For the year ended March 31 2019, Dr Martens saw its revenue jump 30 per cent to £454.4 million, while EBITDA rose 70 per cent to £80 million.
In the financial year to March 31, 2019, Dr Martens opened 20 new stores. It said that 77 per cent of its full year revenue came from outside of the UK.
Click here to sign up to Retail Gazette‘s free daily email newsletter
